Recombinant cytokines in the practice of the therapist-Reference-Cited by-同舟云学术

Recombinant cytokines in the practice of the therapist

Published:2021-05-19 Issue:7 Volume: Page:11-18
ISSN:2075-0277
Container-title:Terapevt (General Physician)
language:ru
Short-container-title:

Author:

Antonenko Margarita Valentinovna¹

Affiliation:

1. LLC «NPK «BIOTECH», St. Petersburg, Russia

Abstract

The article contains information presented in the open press based on the results of studies of the clinical efficacy of recombinant interleukin 2. Roncoleukin provides immune protection against tumor cells, pathogens of viral, bacterial and fungal nature, activates the processes of tissue repair and regeneration, promotes adequate interaction of the immune, endocrine and nervous systems. Interleukin-2 is an activation, proliferation and differentiation factor for T- and B-lymphocytes, T-regulatory cells, natural killer cells, monocytes / macrophages, dendritic and oligodendroglial cells; protects activated T cells from premature death (apoptosis) and cancels immunological tolerance.

Publisher

PANORAMA Publishing House

Reference9 articles.

1. Xu L., Song X.., Su L, Zheng Y., Li R., Sun J. New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases. Int Immunopharmacol. 2019 Jul; 72:322– 329. doi: 10.1016/j.intimp.2019.03.064. Epub 2019 Apr 18

2. Guoyan Cheng, Aixin Yu, Thomas R. Malek T‐cell tolerance and the multi‐functional role of IL‐2R signaling in T‐regulatory cells First published: 13 April 2011 https://doi.org/10.1111/j.1600-065X.2011.01004.x

3. Tsoi O. G., Makishev A. K., Tsoi N. O., Rakhimov S. K., Rytzhanuly I. M. Immunomodulators with direct antitumor action // Medicine of Kyrgyzstan. — 2019. — No. 3. — p. 50–56.

4. Nikitina T. N. Stimulation of the immune response by cytokine preparations and their standardization. Autoref. diss…. candidate of medical sciences. -I. I. Mechnikov Research Institute of Vaccines and Serums of the Russian Academy of Medical Sciences, Moscow, 2010.

5. Toxicological safety of the use of recombinant interleukin-2 in humans. Seventh scientific conference. — practical conference «Actual problems of life safety» (labor protection, ecology, valeology, human protection in emergencies, toxicology, economic aspects of the Belarusian Railways). Vol. 1. — Almaty: KazNTU, 2005. — pp. 355–357.